Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.
Real-world data shows how different treatment approaches have gradually improved survival for myelodysplastic neoplasms over recent decades.
Large German MDS registry analysis evaluating how evolving therapy strategies have influenced overall survival across different treatment decades, providing real-world evidence for treatment trends in myelodysplastic neoplasms. This temporal analysis contextualizes MDS treatment progress and residual gaps.
What the study was
- Study design
- Registry-based retrospective cohort study
- Population
- MDS patients from the German MDS registry across multiple treatment decades
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Annals of Hematology
Why it surfaced
Large MDS registry study informing treatment evolution; moderate signal for MDS surveillance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.